In this Issue:
Combination ART and HPV risk in HIV
Dolutegravir in treatment-naïve HIV
Age-associated comorbidity risk factors in HIV
Lamivudine vs FTC in combination therapy
Home-based vs mobile clinic HIV testing and counselling
PrEP for HIV-1: TDF vs FTC/TDF
Non-use of ART in HIV-positive gay men
Immunologic effects of mesalamine in HIV
Gay and bisexual men’s attitudes to HIV treatment as prevention
HIV-1 drug resistance in the iPrEx PrEP trial
Please login below to download this issue (PDF)